Olivier Rigal

2.0k total citations
51 papers, 1.0k citations indexed

About

Olivier Rigal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Olivier Rigal has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 12 papers in Genetics. Recurrent topics in Olivier Rigal's work include Cancer-related cognitive impairment studies (23 papers), Glioma Diagnosis and Treatment (12 papers) and Brain Metastases and Treatment (11 papers). Olivier Rigal is often cited by papers focused on Cancer-related cognitive impairment studies (23 papers), Glioma Diagnosis and Treatment (12 papers) and Brain Metastases and Treatment (11 papers). Olivier Rigal collaborates with scholars based in France, United States and Luxembourg. Olivier Rigal's co-authors include Florence Joly, Bénédicte Giffard, Marie Lange, Pierre Michel, Sabine Noal, Bénédicte Clarisse, Frédéric Di Fiore, B Paillot, Francis Eustache and H. Hamidou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Olivier Rigal

49 papers receiving 1.0k citations

Peers

Olivier Rigal
Henriette Breunis Canada
AnnaLynn M. Williams United States
Kenneth Y. Usuki United States
Koen Van Eygen Belgium
Kirsten Papsdorf Germany
Helena Harder United Kingdom
Heeyoung Kim United States
L. Claassens Netherlands
Kathryn Bylow United States
Eefje M. Sizoo Netherlands
Henriette Breunis Canada
Olivier Rigal
Citations per year, relative to Olivier Rigal Olivier Rigal (= 1×) peers Henriette Breunis

Countries citing papers authored by Olivier Rigal

Since Specialization
Citations

This map shows the geographic impact of Olivier Rigal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Rigal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Rigal more than expected).

Fields of papers citing papers by Olivier Rigal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Rigal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Rigal. The network helps show where Olivier Rigal may publish in the future.

Co-authorship network of co-authors of Olivier Rigal

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Rigal. A scholar is included among the top collaborators of Olivier Rigal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Rigal. Olivier Rigal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Emilie, Justine Lequesne, Hélène Castel, et al.. (2025). Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study. Breast Cancer Research. 27(1). 25–25. 1 indexed citations
2.
Lequesne, Justine, Antonio Di Meglio, Caroline Pradon, et al.. (2024). Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study. Breast Cancer Research. 26(1). 93–93. 6 indexed citations
3.
Licaj, Idlir, Elodie Coquan, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2023). Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer. 129(7). 1085–1095. 4 indexed citations
4.
Presti, Daniele, Julie Havas, Davide Soldato, et al.. (2022). Factors associated with enrolment in clinical trials among women with early-stage breast cancer. ESMO Open. 7(3). 100513–100513. 2 indexed citations
5.
6.
Meglio, Antonio Di, Cécile Charles, Élise Martin, et al.. (2020). 183O Use of physical activity (PA) and supportive care (SC) among patients (pts) with early breast cancer (BC) reporting cancer-related fatigue (CRF). Annals of Oncology. 31. S83–S83. 1 indexed citations
7.
Joly, Florence, Justine Lequesne, Marie Lange, et al.. (2020). LBA69 Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients. Annals of Oncology. 31. S1200–S1200. 3 indexed citations
8.
Joly, Francisca, Dominique Pasquier, C. Hanzen, et al.. (2016). Impact of art therapy (AT) on fatigue and quality of life (QoL) during adjuvant external beam irradiation (EBI) in breast cancer patients (pts): a randomized trial. Annals of Oncology. 27. vi499–vi499. 3 indexed citations
9.
Joly, Florence, Bénédicte Giffard, Olivier Rigal, et al.. (2015). Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012. Journal of Pain and Symptom Management. 50(6). 830–841. 118 indexed citations
10.
Lecleire, Stéphane, Alice Gangloff, Olivier Rigal, et al.. (2014). Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer. Digestive and Liver Disease. 46(3). 270–275. 28 indexed citations
11.
Lange, Marie, Bénédicte Giffard, Sabine Noal, et al.. (2014). Baseline cognitive functions among elderly patients with localised breast cancer. European Journal of Cancer. 50(13). 2181–2189. 62 indexed citations
12.
Lange, Marie, Olivier Rigal, Bénédicte Clarisse, et al.. (2014). Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists. Cancer Treatment Reviews. 40(6). 810–817. 89 indexed citations
13.
14.
Falandry, Claire, Étienne Brain, Marc Bonnefoy, et al.. (2013). Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial. European Journal of Cancer. 49(13). 2806–2814. 28 indexed citations
15.
Joly, Florence, Marie Lange, Olivier Rigal, et al.. (2012). French version of the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog) version 3. Supportive Care in Cancer. 20(12). 3297–3305. 67 indexed citations
16.
Fiore, F. Di, et al.. (2011). Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib. British Journal of Cancer. 105(12). 1811–1813. 42 indexed citations
17.
18.
Fiore, Frédéric Di, Stéphane Lecleire, Daniela Pop, et al.. (2007). Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer. The American Journal of Gastroenterology. 102(11). 2557–2563. 142 indexed citations
19.
Tougeron, David, Frédéric Di Fiore, H. Hamidou, et al.. (2007). Response to Definitive Chemoradiotherapy and Survival in Patients with an Oesophageal Adenocarcinoma versus Squamous Cell Carcinoma: A Matched-Pair Analysis. Oncology. 73(5-6). 328–334. 17 indexed citations
20.
Fiore, Frédéric Di, Stéphane Lecleire, Marie‐Pierre Galais, et al.. (2006). Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroentérologie Clinique et Biologique. 30(6-7). 845–851. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henriette Breunis Breakdown of academic impact, for papers by AnnaLynn M. Williams Breakdown of academic impact, for papers by Kenneth Y. Usuki Breakdown of academic impact, for papers by Koen Van Eygen Breakdown of academic impact, for papers by Kirsten Papsdorf Breakdown of academic impact, for papers by Helena Harder Breakdown of academic impact, for papers by Heeyoung Kim Breakdown of academic impact, for papers by L. Claassens Breakdown of academic impact, for papers by Kathryn Bylow Breakdown of academic impact, for papers by Eefje M. Sizoo
Rankless by CCL
2026